{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:42:57Z","timestamp":1776231777362,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cognitive impairment (CI) is a prevalent and debilitating non-motor symptom in Parkinson\u2019s disease (PD), yet reliable early diagnostic biomarkers are lacking. This study aimed to identify serum biomarkers associated with PD-CI and investigate the synergistic contributions of lipid metabolism and inflammatory signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective, cross-sectional study, six candidate proteins (INPP5D, FLNA, ICAM-1, PCSK9, JAK1, and LCAT) were selected based on our previously published discovery-phase serum proteomics analysis and were quantified via ELISA in an independent cohort of 75 PD patients and 35 age-matched healthy controls (HCs). All participants underwent comprehensive cognitive assessments (MoCA, MMSE, CDR). Multivariate regression, receiver operating characteristic (ROC) analysis, and bioinformatics tools were employed to evaluate diagnostic potential and pathway associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PD patients showed significantly lower MoCA and MMSE scores than HC, accompanied by elevated serum ICAM-1, PCSK9, and JAK1, and decreased INPP5D and FLNA. Notably, as MoCA scores declined, serum ICAM-1, PCSK9, JAK1, and LCAT levels gradually increased, while INPP5D and FLNA decreased. ROC analysis indicated that these biomarkers, particularly PCSK9 and LCAT, effectively distinguished PD-NC from PD-CI. Bioinformatics analyses highlighted focal adhesion and JAK-STAT signaling as key pathways, with ICAM1 and ITGB2 as central nodes in the protein\u2013protein interaction network.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>All six serum biomarkers showed potential in distinguishing PD-NC from PD-CI, with PCSK9 and LCAT being the most effective. The findings propose a pathogenic cascade integrating neuroinflammation, lipid metabolism, and cell adhesion dysfunction, offering new mechanistic insights and potential avenues for early diagnosis and therapeutic intervention in PD-CI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyg.2026.1789929","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:43:34Z","timestamp":1776228214000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["High-efficacy serum biomarkers PCSK9 and LCAT predict cognitive impairment in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Mingyu","family":"Su","sequence":"first","affiliation":[{"name":"Department of Neurobiology, Xuzhou Key Laboratory of Neurobiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianshu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Xuzhou Key Laboratory of Neurobiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]},{"name":"School of Public Health, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinrui","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Xuzhou Key Laboratory of Neurobiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyu","family":"Qiang","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Xuzhou Key Laboratory of Neurobiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]},{"name":"First School of Clinical Medicine, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihan","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Xuzhou Key Laboratory of Neurobiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Xuzhou Key Laboratory of Neurobiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linyun","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Xuzhou Key Laboratory of Neurobiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Huaian Second People's Hospital","place":["Huaian, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanxi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Xuzhou Key Laboratory of Neurobiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Xuzhou Key Laboratory of Neurobiology, Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]},{"name":"Xuzhou Oriental People\u2019s Hospital Affiliated to Xuzhou Medical University","place":["Xuzhou, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jns.2009.08.034","article-title":"The epidemiology of dementia associated with Parkinson disease","volume":"289","author":"Aarsland","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/biology14060699","article-title":"Protective effects of extracts from green leaves and rhizomes of Posidonia oceanica (L.) Delile on an in vitro model of the human blood-brain barrier","volume":"14","author":"Abruscato","year":"2025","journal-title":"Biology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/0972-6748.110948","article-title":"Effects of age, stage of disease, and educational level on cognitive dysfunction in non-demented idiopathic Parkinsonism: a preliminary report","volume":"21","author":"Adhikari","year":"2012","journal-title":"Ind. Psychiatry J."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1212\/wnl.0000000000207193","article-title":"Blood biomarkers in neurodegenerative diseases: implications for the clinical neurologist","volume":"101","author":"Alcolea","year":"2023","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e1245232024","DOI":"10.1523\/jneurosci.1245-23.2024","article-title":"Reducing filamin a restores cortical synaptic connectivity and early social communication following cellular mosaicism in autism spectrum disorder pathways","volume":"44","author":"Binder","year":"2024","journal-title":"J. Neurosci."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/jlb.2mr0220-549r","article-title":"ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis","volume":"108","author":"Bui","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.20517\/2347-8659.2017.50","article-title":"Altered filamin a enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer's disease","volume":"4","author":"Burns","year":"2017","journal-title":"Neuroimmunol. Neuroinflamm."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1165\/rcmb.2024-0438OC","article-title":"GP IIb\/IIIa-ICAM-1 mediated platelet-endothelial adhesion exacerbates pulmonary hypertension","volume":"73","author":"Chen","year":"2025","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.1038\/s41467-023-42819-w","article-title":"INPP5D regulates inflammasome activation in human microglia","volume":"14","author":"Chou","year":"2023","journal-title":"Nat. Commun."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"103313","DOI":"10.1016\/j.ebiom.2021.103313","article-title":"Blood biomarkers of neurodegeneration-progress on non-invasive diagnostics","volume":"65","year":"2021","journal-title":"EBioMedicine"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.22365\/jpsych.2019.301.66","article-title":"Depression and financial capacity assessment in Parkinson's disease with dementia: overlooking an important factor?","volume":"30","author":"Giannouli","year":"2019","journal-title":"Psychiatriki"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/brainsci11060785","article-title":"Is depression or apathy playing a key role in predicting financial capacity in Parkinson's disease with dementia and frontotemporal dementia?","volume":"11","author":"Giannouli","year":"2021","journal-title":"Brain Sci."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson's disease and parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am. J. Med."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e066086","DOI":"10.1002\/alz.066086","article-title":"Altered HDL cholesterol efflux capacity and LCAT activity is APOE-specific in Alzheimer disease and mild cognitive impairment patients","volume":"18","author":"Hong","year":"2022","journal-title":"Alzheimers Dement."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12974-024-03210-8","article-title":"Suppression of the JAK\/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson's disease","volume":"21","author":"Hong","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11064-024-04282-x","article-title":"Neuroprotective effect of Maresin-1 in rotenone-induced Parkinson's disease in rats: the putative role of the JAK\/STAT pathway","volume":"50","author":"Khodir","year":"2024","journal-title":"Neurochem. Res."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/mol.0000000000000114","article-title":"PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells","volume":"25","author":"Lagace","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2016.04.009","article-title":"Cognitive decline and quality of life in incident Parkinson's disease: the role of attention","volume":"27","author":"Lawson","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41531-023-00476-2","article-title":"Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD","volume":"9","author":"Lerche","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/0891988712464823","article-title":"Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden","volume":"25","author":"Leroi","year":"2012","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1212\/01.wnl.0000036610.36834.e0","article-title":"The association of incident dementia with mortality in PD","volume":"59","author":"Levy","year":"2002","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12964-025-02071-9","article-title":"\u03b22 integrin regulates neutrophil trans endothelial migration following traumatic brain injury","volume":"23","author":"Li","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/alz.12849","article-title":"INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease","volume":"19","author":"Lin","year":"2023","journal-title":"Alzheimers Dement."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1016\/j.ygeno.2020.04.025","article-title":"Next generation sequencing exome data analysis aids in the discovery of SNP and INDEL patterns in Parkinson's disease","volume":"112","author":"Odumpatta","year":"2020","journal-title":"Genomics"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13293-024-00602-6","article-title":"Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysis","volume":"15","author":"Pott","year":"2024","journal-title":"Biol. Sex Differ."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13293-025-00692-w","article-title":"Sex and gender differences in the molecular etiology of Parkinson's disease: considerations for study design and data analysis","volume":"16","author":"Schaffner","year":"2025","journal-title":"Biol. Sex Differ."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/jbt.70011","article-title":"miR-148a-3p mitigation of coronary artery disease through PCSK9\/NF-\u03baB inhibition of vascular endothelial cell injury","volume":"38","author":"Tang","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3233\/jad-220086","article-title":"Parkinson's disease rs117896735 variant regulates INPP5F expression in brain tissues and increases risk of Alzheimer's disease","volume":"89","author":"Xue","year":"2022","journal-title":"J. Alzheimer's Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"6734678","DOI":"10.1155\/2016\/6734678","article-title":"Parkinson's disease and cognitive impairment","volume":"2016","author":"Yang","year":"2016","journal-title":"Parkinson's Dis."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"112677","DOI":"10.1016\/j.biopha.2022.112677","article-title":"LCAT-targeted therapies: progress, failures and future","volume":"147","author":"Yang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e0327085","DOI":"10.1371\/journal.pone.0327085","article-title":"Cl-amidine confers organ protection and improves survival in hemorrhagic shock rats via the PAD4-CitH3-NETs axis","volume":"20","author":"Yun","year":"2025","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e18081","DOI":"10.1016\/j.heliyon.2023.e18081","article-title":"Clinical characteristics and reaction to dopaminergic treatment of drug-na\u00efve patients with Parkinson's disease in Central China: a cross sectional study","volume":"9","author":"Zeng","year":"2023","journal-title":"Heliyon"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"110989","DOI":"10.1016\/j.brainresbull.2024.110989","article-title":"ICAM-1 may promote the loss of dopaminergic neurons by regulating inflammation in MPTP-induced Parkinson's disease mouse models","volume":"214","author":"Zhang","year":"2024","journal-title":"Brain Res. Bull."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3233\/jad-160411","article-title":"Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer's disease","volume":"55","author":"Zimetti","year":"2017","journal-title":"J. Alzheimers Dis."}],"container-title":["Frontiers in Psychology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2026.1789929\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:43:37Z","timestamp":1776228217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2026.1789929\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":35,"alternative-id":["10.3389\/fpsyg.2026.1789929"],"URL":"https:\/\/doi.org\/10.3389\/fpsyg.2026.1789929","relation":{},"ISSN":["1664-1078"],"issn-type":[{"value":"1664-1078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"1789929"}}